Targeting B Cells in SLE: The Experience with Rituximab Treatment (Anti-CD20)

Publisher: Bentham Science Publishers

E-ISSN: 2212-3873|6|4|345-350

ISSN: 1871-5303

Source: Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.6, Iss.4, 2006-12, pp. : 345-350

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content